Call for Abstract

2nd International Conference and Exhibition on Cell & Gene Therapy, will be organized around the theme “Innovative Strategies in Cell & Gene Therapies”

Cell Therapy-2013 is comprised of 10 tracks and 71 sessions designed to offer comprehensive sessions that address current issues in Cell Therapy-2013.

Submit your abstract to any of the mentioned tracks. All related abstracts are accepted.

Register now for the conference by choosing an appropriate package suitable to you.

  • Track 1-1Molecular therapy
  • Track 1-2Ocular therapy
  • Track 1-3Neuro therapy for neurological diseases
  • Track 1-4Cardiac cell therapy
  • Track 1-5Cell therapies for renal failure
  • Track 1-6RNA therapeutics
  • Track 1-7Virotherapy
  • Track 2-1Molecular basis of pluripotency
  • Track 2-2Bone marrow stem cells as therapy
  • Track 2-3Current views of the embryonic & neural stem cells
  • Track 2-4Stem cell therapy for genetic disorders
  • Track 2-5Targeting stem cells for therapeutic benefits
  • Track 2-6Transplantation technologies in stem cell therapy
  • Track 3-1Cell replacement therapy
  • Track 3-2Potential uses of defined cell populations
  • Track 3-3Reprogramming cell fate
  • Track 3-4Role of molecular markers in therapies
  • Track 3-5Target tissues and routes of delivery
  • Track 3-6Causes of regenerative failure
  • Track 4-1Tumour suppressor genes
  • Track 4-2Biomarkers involved in gene therapy
  • Track 4-3Genetic screening & diagnostics
  • Track 4-4Cloning & expression systems
  • Track 4-5Mobile genetic elements
  • Track 4-6Vectors for gene therapy
  • Track 4-7Cellular & organismal genetic engineering
  • Track 4-8Gene transfer to induce cellular programming
  • Track 4-9Therapies for genetic disorders/autoimmune disorders
  • Track 4-10Molecular basis of epigenetics
  • Track 5-1Cell based immunotherapy
  • Track 5-2Cancers of immune cells
  • Track 5-3New cell therapies for allergies
  • Track 5-4Cell based immunosuppression in transplantation
  • Track 5-5Tumour cells evade/defeat immune system
  • Track 5-6Bio-Immune cellular therapy
  • Track 6-1Stem cells & cancer treatments
  • Track 6-2Characteristics of cancer cells
  • Track 6-3Cell cycle and oncology
  • Track 6-4Modern approaches in molecular cancer therapeutics
  • Track 6-5Genomics & cancer drug resistance
  • Track 6-6Cancer stem cells as a valuable target for diagnostic and therapy
  • Track 6-7Genetically engineered cancer vaccines
  • Track 6-8Therapeutic cancer vaccines
  • Track 6-9Challenges & risks of cancer gene therapy
  • Track 7-1Nano methods to target cancer cells
  • Track 7-2Nano-microfluidics in cell therapy
  • Track 7-3Nano materials and nano engineering
  • Track 7-4Pros and cons of molecular manufacturing
  • Track 7-5 Nanovaccines
  • Track 8-1Biomedical engineering
  • Track 8-2Developing new probes for tissue targeting
  • Track 8-3Therapeutic bioengineering
  • Track 8-4Cellular mechanobiology
  • Track 8-5Tissue engineering from own stem cells
  • Track 8-6Current understanding & challenges in bioprocessing
  • Track 8-7Bioengineering for medical diagnostics and imaging
  • Track 9-1Principles of gene therapy & clinical gene therapy
  • Track 9-2Animal & human trials of engineered tissues
  • Track 9-3Emerging clinical aspects of stem cell therapy
  • Track 9-4Pharmacogenomics in cell therapy
  • Track 9-5Clinical trial design and analysis
  • Track 9-6 Clinical genetics
  • Track 9-7Alternative lab models for therapeutic applications
  • Track 10-1Commercialisation strategy
  • Track 10-2Applications of cell therapy: From bench to bedside
  • Track 10-3Cell therapy in future medicine
  • Track 10-4Ethics involved in human stem cells
  • Track 10-5Logistics in preparing lab models for cell therapy applications
  • Track 10-6Manufacturing of cell therapy products and marketing guidelines
  • Track 10-7Innovative therapeutic technologies
  • Track 10-8FDA & EMA guidelines